# Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced Gastritis

> **NCT07312721** · PHASE4 · COMPLETED · sponsor: **Azfar Farogh** · enrollment: 752 (actual)

## Conditions studied

- Helicobacter Pylori Infection
- Chronic Gastritis
- Peptic Ulcer Disease

## Interventions

- **DRUG:** Triple Therapy
- **DRUG:** Quadruple Therapy

## Key facts

- **NCT ID:** NCT07312721
- **Lead sponsor:** Azfar Farogh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-05
- **Primary completion:** 2024-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 752 (ACTUAL)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07312721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07312721, "Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced Gastritis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT07312721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*